propranolol + clonidine

This is a combination of two antihypertensive agents, propranolol and clonidine. Propranolol is a nonselective beta-adrenergic receptor antagonist (beta-blocker) that reduces blood pressure by blocking beta-1 and beta-2 adrenergic receptors, leading to decreased heart rate, cardiac output, and suppression of renin release. Clonidine is an alpha-2 adrenergic receptor agonist that lowers blood pressure primarily by decreasing sympathetic outflow from the central nervous system. When used together, these drugs have additive antihypertensive effects but can also increase the risk of bradycardia (slow heart rate), hypotension (low blood pressure), and atrioventricular block due to synergistic pharmacodynamic actions[1][2][3][6]. This combination may be considered in resistant hypertension but requires careful monitoring due to increased side effect risks.